skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; more »; ; ; ;  [1] « less
  1. Novartis
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
INDUSTRY
OSTI Identifier:
1545839
Resource Type:
Journal Article
Journal Name:
J. Med. Chem.
Additional Journal Information:
Journal Volume: 61; Journal Issue: (7) ; 04, 2018
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Tria, George S., Abrams, Tinya, Baird, Jason, Burks, Heather E., Firestone, Brant, Gaither, L. Alex, Hamann, Lawrence G., He, Guo, Kirby, Christina A., Kim, Sunkyu, Lombardo, Franco, Macchi, Kaitlin J., McDonnell, Donald P., Mishina, Yuji, Norris, John D., Nunez, Jill, Springer, Clayton, Sun, Yingchuan, Thomsen, Noel M., Wang, Chunrong, Wang, Jianling, Yu, Bing, Tiong-Yip, Choi-Lai, Peukert, Stefan, and Duke-MED). Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer. United States: N. p., 2019. Web. doi:10.1021/acs.jmedchem.7b01682.
Tria, George S., Abrams, Tinya, Baird, Jason, Burks, Heather E., Firestone, Brant, Gaither, L. Alex, Hamann, Lawrence G., He, Guo, Kirby, Christina A., Kim, Sunkyu, Lombardo, Franco, Macchi, Kaitlin J., McDonnell, Donald P., Mishina, Yuji, Norris, John D., Nunez, Jill, Springer, Clayton, Sun, Yingchuan, Thomsen, Noel M., Wang, Chunrong, Wang, Jianling, Yu, Bing, Tiong-Yip, Choi-Lai, Peukert, Stefan, & Duke-MED). Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer. United States. doi:10.1021/acs.jmedchem.7b01682.
Tria, George S., Abrams, Tinya, Baird, Jason, Burks, Heather E., Firestone, Brant, Gaither, L. Alex, Hamann, Lawrence G., He, Guo, Kirby, Christina A., Kim, Sunkyu, Lombardo, Franco, Macchi, Kaitlin J., McDonnell, Donald P., Mishina, Yuji, Norris, John D., Nunez, Jill, Springer, Clayton, Sun, Yingchuan, Thomsen, Noel M., Wang, Chunrong, Wang, Jianling, Yu, Bing, Tiong-Yip, Choi-Lai, Peukert, Stefan, and Duke-MED). Fri . "Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer". United States. doi:10.1021/acs.jmedchem.7b01682.
@article{osti_1545839,
title = {Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer},
author = {Tria, George S. and Abrams, Tinya and Baird, Jason and Burks, Heather E. and Firestone, Brant and Gaither, L. Alex and Hamann, Lawrence G. and He, Guo and Kirby, Christina A. and Kim, Sunkyu and Lombardo, Franco and Macchi, Kaitlin J. and McDonnell, Donald P. and Mishina, Yuji and Norris, John D. and Nunez, Jill and Springer, Clayton and Sun, Yingchuan and Thomsen, Noel M. and Wang, Chunrong and Wang, Jianling and Yu, Bing and Tiong-Yip, Choi-Lai and Peukert, Stefan and Duke-MED)},
abstractNote = {},
doi = {10.1021/acs.jmedchem.7b01682},
journal = {J. Med. Chem.},
number = (7) ; 04, 2018,
volume = 61,
place = {United States},
year = {2019},
month = {7}
}